FUNDING SIGNALS

Real Signals. Real Leads. Real Deals.

The only platform that turns real-time signals into your perfect leads

Know Who, Why, and When to reach out — instantly.

FundzWatch™ AI Scoring

10-25 leads daily

Real-time alerts

★★★★★

4.8/5 on G2• High Performer Fall 2025

Used by teams at LinkedIn, HubSpot & Oracle

🔒 app.fundz.net

💰Series B - $40M

2 days ago

📈Revenue 3x YoY

1 week ago

🚀Expansion Plans

2 weeks ago

💡 Multiple signals = high buying intent

Third Pole Therapeutics Closes $25M Financing - Enofit™ Wearable Device Now Ready For Clinical Trials

Feb 03, 2022•over 3 years ago

Amount Raised

$25 Million

WalthamHealth CareMedicalManufacturing

Description

Third Pole Therapeutics, a privately held company developing critical life-sustaining cardio-pulmonary therapies, announced today that it has achieved several significant milestones that include closing a $25M round of financing, and that eNOfitTM, the Company's fully miniaturized wearable device, is ready for clinical trials.

Company Information

Company

Third Pole

Location

309 WAVERLEY OAKS ROAD

Waltham, Massachusetts, United States

About

Third Pole, Inc. is a US-based company developing next generation life-saving cardiopulmonary therapies. We are building on our team’s legacy in inhaled nitric oxide (NO), the current standard of care, to develop next generation life-saving heart and lung therapies. Our first product is being designed to be a simple, convenient, economical, and lightweight device capable of generating nitric oxide from air on-demand and on-site which potentially eliminates the need for large compressed gas cylinders. We believe our novel approach of creating NO on demand has the promise to create new markets by enabling the worldwide use of inhaled NO in settings outside of acute care.

Company News

(2 articles)

Tue, 26 Mar 2019 07:00:00 GMT

Third Pole Therapeutics Announces Inhaled Nitric Oxide Strategic Collaboration with Actelion, a Janssen Pharmaceutical Company of Johnson & Johnson - PR Newswire

Tue, 20 Jun 2000 07:00:00 GMT

Pole: CD 3 Album Review - Pitchfork

FundzWatch™ Score

100

High Activity

15 total signals

Buyer Intent Analysis

Get personalized insights on buying likelihood

Related People

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech